Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity–emerging roles in obesity, intestinal inflammation, and cancer
- 13 April 2016
- journal article
- review article
- Published by Wiley in European Journal of Immunology
- Vol. 46 (5) , 1091-1100
Abstract
Interleukin (IL)‐33, a member of the IL‐1 family, was originally described in 2005 as a potent initiator of type 2 immunity found during allergic inflammation and parasitic infections. IL‐33 has been shown to play important and potent roles bridging innate and adaptive immunity in the regulation of tissue homeostasis, injury, and repair. Recent discoveries have extended the range of functions for IL‐33 beyond type 2 conditions and its role as an alarmin at barrier sites, with emerging central roles for IL‐33 in T‐cell regulation, obesity, viral and tumor immunity. Here, we review the recent advances on how IL‐33 activity is regulated, its immunomodulatory properties on innate and adaptive cells, and the newly discovered roles of IL‐33 in obesity, intestinal inflammation, and tumorigenesis.Keywords
Funding Information
- Science Foundation Ireland (SFI) and National Children's Research Centre
- SFI (12/IA/1421)
- SFI Research Centre, Advanced Materials and BioEngineering Research (AMBER) (SFI/12/RC/2278)
This publication has 95 references indexed in Scilit:
- IL-33 attenuates development and perpetuation of chronic intestinal inflammationInflammatory Bowel Diseases, 2012
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin GProceedings of the National Academy of Sciences, 2012
- IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cellsEuropean Journal of Immunology, 2011
- An Essential Role of the Transcription Factor GATA-3 for the Function of Regulatory T CellsImmunity, 2011
- Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunityNature Immunology, 2011
- Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling ComplexesStructure, 2009
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences, 2009
- IL-33–activated dendritic cells induce an atypical TH2-type responseJournal of Allergy and Clinical Immunology, 2009
- Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocketEMBO Reports, 2008
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007